Efficacy of Unani drugs on Melasma

A Comparative Clinical Study on the Efficacy of Joshanda Haleela Siyah with Tila-e-Tukhm Turb and Tukhm Jarjir vs Tukhm Kharpazah and Aard Baqla in Kalaf (Melasma)

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/04/041617

Enrollment

Registered

2022-04-04

Start date

Unknown

Completion date

Unknown

Last updated

2022-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L814- Other melanin hyperpigmentation

Interventions

Intervention1: Haleela Siyah Tukhme Turb and Tukhme Jarjir: Haleela Siyah 10g Tukhme Turb 5g Tukhme Jarjir 5g 10 gm of Haleela Siyah will be soak overnight in 150 ml of water and its Decoction will

Eligibility

Inclusion criteria

Inclusion criteria: Patients with Fitzpatrick Skin phototype 3rd to 6th Patients m MASI Score up to Marked in Darkness (0-3) and Duration of Melasma Patient willing for study

Exclusion criteria

Exclusion criteria: Pregnant and Lactating women Patients with systemic disease e.g. Malignancy, Thyroid Dysfunction, CKD, Tuberculosis. History of any Skin therapies related to Hyperpigmentation History of Hypersensitivity Reaction with Drugs. Severe Cases of Melasma

Design outcomes

Primary

Measure	Time frame
Reversal of mMASI, PGA, PtGA, scores Change in photographic lesionTimepoint: 28 days	—

Secondary

Measure	Time frame
NATimepoint: NA	—

Countries

India

Contacts

Public ContactDr Mohd Aleemuddin Quamri

National Institute of Unani Medicine

tubazulfar786@gmail.com9987159752

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026